858 related articles for article (PubMed ID: 29674323)
1. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
2. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
4. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
[TBL] [Abstract][Full Text] [Related]
5. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
[TBL] [Abstract][Full Text] [Related]
6. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
7. Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A
Hobabagabo AF; Osei-Tutu NH; Hormenu T; Shoup EM; DuBose CW; Mabundo LS; Ha J; Sherman A; Chung ST; Sacks DB; Sumner AE
Diabetes Care; 2020 Oct; 43(10):2607-2613. PubMed ID: 32801129
[TBL] [Abstract][Full Text] [Related]
8. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
9. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Sato A
Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
[TBL] [Abstract][Full Text] [Related]
10. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
[TBL] [Abstract][Full Text] [Related]
11. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
Scully KJ; Sherwood JS; Martin K; Ruazol M; Marchetti P; Larkin M; Zheng H; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Wexler DJ; Putman MS
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1444-e1454. PubMed ID: 34850006
[TBL] [Abstract][Full Text] [Related]
12. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
[TBL] [Abstract][Full Text] [Related]
14. The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus.
Shima K; Abe F; Chikakiyo H; Ito N
Diabetes Res Clin Pract; 1989 Nov; 7(4):243-50. PubMed ID: 2612342
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
16. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
Desouza CV; Rosenstock J; Zhou R; Holcomb RG; Fonseca VA
Endocr Pract; 2015 Nov; 21(11):1195-203. PubMed ID: 26214108
[TBL] [Abstract][Full Text] [Related]
17. A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.
Sumner AE; Duong MT; Aldana PC; Ricks M; Tulloch-Reid MK; Lozier JN; Chung ST; Sacks DB
Diabetes Care; 2016 Feb; 39(2):271-7. PubMed ID: 26681716
[TBL] [Abstract][Full Text] [Related]
18. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
19. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
20. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]